Kobenhavns universitet - biomarkers of progression of oral leukoplakia to oral cancer

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700613P
Awardee
Awarding agency
Obligated
$39,999

Award facts

Opportunity
Contract value 100% obligated
$39,999.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Denmark

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a purchase order to Kobenhavns Universitet valued at $39,999.30 on September 18, 2017, for biomarkers of progression of oral leukoplakia to oral cancer. Performance is in Denmark under firm fixed price terms. The order was completed on September 17, 2018.

Quick answers

Who was awarded contract HHSN261201700613P?

HHSN261201700613P was awarded to Kobenhavns Universitet by National Cancer Institute (National Institutes of Health) on September 18, 2017.

How much is contract HHSN261201700613P worth?

The government has obligated $39,999 on HHSN261201700613P.

Was contract HHSN261201700613P competed?

The extent of competition for HHSN261201700613P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award